Reumatoloxía

2019

1. 2018 update of the EULAR recommendations for the management of hand osteoarthritis

   Annals of the Rheumatic Diseases, Vol. 78, Núm. 1, pp. 16-24

2. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

   Annals of the Rheumatic Diseases, Vol. 78, Núm. 9, pp. 1151-1159

3. A Phase II Trial of Lutikizumab, an Anti–Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis

   Arthritis and Rheumatology, Vol. 71, Núm. 7, pp. 1056-1069

4. A combined transcriptomic and genomic analysis identifies a gene signature associated with the response to anti-TNF therapy in rheumatoid arthritis

   Frontiers in Immunology, Vol. 10, Núm. JUL

5. A composite indicator to assess the quality of care in the management of patients with rheumatoid arthritis in outpatient rheumatology clinics

   Reumatologia Clinica, Vol. 15, Núm. 3, pp. 156-164

6. Abatacept for the treatment of rheumatoid arthritis

   Expert Review of Clinical Immunology, Vol. 15, Núm. 4, pp. 319-326

7. Adherence to biological therapies in patients with chronic inflammatory arthropathies

   Farmacia Hospitalaria, Vol. 43, Núm. 4, pp. 134-139

8. Adherence to synthetic disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Results of the OBSERVAR Study

   Reumatologia Clinica, Vol. 15, Núm. 5, pp. 264-270

9. Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases

   Biochemical Pharmacology, Vol. 165, pp. 196-206

10. Analysis of endogenous peptides released from osteoarthritic cartilage unravels novel pathogenic markers

    Molecular and Cellular Proteomics, Vol. 18, Núm. 10, pp. 2018-2028

11. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

    American Journal of Ophthalmology, Vol. 200, pp. 85-94

12. Anti-inflammatory effects of novel standardized platelet rich plasma releasates on knee osteoarthritic chondrocytes and cartilage in vitro

    Current Pharmaceutical Biotechnology, Vol. 20, Núm. 11, pp. 920-933

13. Association of Functional Polymorphisms of KIR3DL1/DS1 With Behçet's Disease

    Frontiers in Immunology, Vol. 10

14. Behçet’s disease and genetic interactions between HLA-B*51 and variants in genes of autoinflammatory syndromes

    Scientific Reports, Vol. 9, Núm. 1

15. Can we validate a clinical score to predict the risk of severe infection in patients with systemic lupus erythematosus? A longitudinal retrospective study in a British Cohort

    BMJ Open, Vol. 9, Núm. 6

16. Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASAR

    Clinical Rheumatology, Vol. 38, Núm. 8, pp. 2129-2139

17. Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study

    Rheumatology International, Vol. 39, Núm. 12, pp. 2015-2024

18. Commercially available antibiotic-laden PMMA-covered locking nails for the treatment of fracture-related infections - A retrospective case analysis of 10 cases

    Journal of Bone and Joint Infection, Vol. 4, Núm. 4, pp. 155-162

19. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

    Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089

20. Content analysis of Twitter in relation to biological treatments for chronic inflammatory arthropathies: An exploratory study

    European Journal of Hospital Pharmacy , Vol. 26, Núm. 3, pp. 124-128